ASND – ascendis pharma a/s - american depositary shares (US:NASDAQ)
Stock Stats
News
3/25
05:05 pm
asnd
Low
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization [Yahoo! Finance]
3/20
09:28 pm
asnd
Low
Ascendis Pharma Trial Wins And Valuation Gap Draw Investor Attention [Yahoo! Finance]
3/17
09:05 am
asnd
Low
New InsiGHTS Trial of TransCon® hGH (Lonapegsomatropin) in Turner Syndrome Demonstrated Comparable Efficacy and Safety to Daily Somatropin at Week 52 [Yahoo! Finance]
3/17
08:30 am
asnd
Low
New InsiGHTS Trial of TransCon® hGH (Lonapegsomatropin) in Turner Syndrome Demonstrated Comparable Efficacy and Safety to Daily Somatropin at Week 52
3/16
10:58 am
asnd
Low
Ascendis Pharma A/S (ASND) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
2/11/2026
04:01 pm
asnd
-1.5%
MISS
11/12/2025
04:01 pm
asnd
3.1%
MISS
8/7/2025
04:01 pm
asnd
0.6%
BEAT
5/1/2025
04:01 pm
asnd
2.7%
MISS
3/16
02:09 pm
Assumes
Buy
Buy
Jefferies
Low
0.3%
3/16
02:09 pm
Assumes
Buy
Buy
Jefferies
Low
0.3%
3/5
05:03 pm
Reiterates
Buy
Buy
Bank of America Corporation
Low
1.4%
3/3
10:33 am
Maintains
Outperform
Outperform
RBC Capital
Low
0.3%
3/3
10:33 am
Maintains
Outperform
Outperform
RBC Capital
Low
0.3%
4/1
04:10 pm
asnd
Low
Form 3 Ascendis Pharma A/S For: Mar 23 Filed by: BIENAIME JEAN JACQUES
3/30
05:30 pm
asnd
Medium
Form 6-K Ascendis Pharma A/S For: Mar 30
3/24
04:05 pm
asnd
Low
Form 6-K Ascendis Pharma A/S For: Mar 24
3/18
06:15 pm
asnd
Low
Form 3 Ascendis Pharma A/S For: Mar 18 Filed by: Fairey William
3/18
06:14 pm
asnd
Low
Form 3 Ascendis Pharma A/S For: Mar 18 Filed by: IMANI SIHAM
Show more
Top News Gainers
4/20 Ascendis Pharma A/S (NASDAQ: ASND) had its price target raised by analysts at Oppenheimer Holdings Inc. from $199.00 to $219.00. They now have an "outperform" rating on the stock. 9.1%
11/18 Ascendis Pharma A/S Reports Third Quarter 2019 Financial Results 6.3%
6/3 Ascendis Pharma A/S (NASDAQ: ASND) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $223.00 price target on the stock, up previously from $219.00. 6.0%
6/14 Form 6-K Ascendis Pharma A/S For: Jun 14 5.5%
11/22 Ascendis Pharma A/S (NASDAQ: ASND) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.3%
12/17 Ascendis Pharma A/S (NASDAQ: ASND) had its price target raised by analysts at Morgan Stanley from $134.00 to $140.00. They now have an "overweight" rating on the stock. 4.6%
12/25 Ascendis Pharma A/S (NASDAQ: ASND) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 4.1%
10/10 Form 6-K Ascendis Pharma A/S For: Oct 10 3.8%
11/20 Edited Transcript of ASND earnings conference call or presentation 18-Nov-19 9:30pm GMT [Yahoo! Finance News] 3.7%
4/14 Ascendis Pharma A/S (NASDAQ: ASND) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 3.6%
Top News Decliners
6/26 Form 6-K Ascendis Pharma A/S For: Jun 26 -9.8%
9/26 Ascendis Pharma A/S Announces Upcoming Investor Presentation in October -7.5%
4/20 Form 6-K Ascendis Pharma A/S For: Apr 20 -5.8%
5/30 Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.4%
8/29 Ascendis Pharma A/S (ASND) Q2 2019 Earnings Call Transcript [The Motley Fool] -5.2%
3/31 Sofinnova Investments Strengthens Executive Team with Promotions of Maha Katabi, PhD, CFA and Sarah Bhagat, PhD -5.0%
11/15 Form 6-K Ascendis Pharma A/S For: Nov 15 -4.2%
7/1 Form 6-K Ascendis Pharma A/S For: Jul 01 -3.9%
4/2 Ascendis Pharma A/S (ASND) Q4 2019 Earnings Call Transcript [The Motley Fool] -3.6%
6/10 Form SC 13G/A Ascendis Pharma A/S Filed by: PRICE T ROWE ASSOCIATES INC /MD/ -3.5%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3